Evidence map›Paper›PMID 40357772›Full record

ArticleCurrent topics in medicinal chemistry2025

Discovery of MMP1 Inhibitors from Dandelion using Molecular Simulation and Bioactivity Test.

Yaxuan Huang, Dewen Jiang, Liqin Zhang, Yonghao Zhang, Mingkai Wu, Xiaojie Jin, Jianjun Luo, Dabo Pan

Abstract read
PubMed Publisher
In one paragraph

Article in Current topics in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaxuan HuangDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.
Dewen JiangDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.
Liqin ZhangDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.
Yonghao ZhangDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.
Mingkai WuDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.
Xiaojie JinCollege of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Jianjun LuoDepartment of Pharmacy, The Affiliated Dazu's Hospital of Chongqing Medical University, Chongqing 402360, China.
Dabo PanDepartment of Medical Technology, Qiandongnan Vocational and Technical College for Nationalities, Kaili 556000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMMP1 (matrix metallopeptidase 1) plays a significant role in the degradation of collagen fibres within the extracellular matrix, and has been linked to a multitude of biological processes, including rheumatoid arthritis, osteoarthritis, periodontal disease, and tumor invasion.

objectiveIn order to discover inhibitors of MMP1 that originate from the phytochemicals of the dandelion (

methodsThe herbal constituents of the dandelion were retrieved from the HERB database. A multifaceted approach including molecular docking, MMP1 enzyme assays, and molecular dynamics simulations was used to identify potential MMP1 inhibitors among the chemical compounds present in the dandelion.

resultsA total of 61 chemical constituents of the dandelion were collated from the HERB database. A potential MMP1 inhibitor was identified through a combination of molecular docking and an MMP1 enzyme bioactivity assay. Cichoric acid demonstrated pronounced inhibitory activity against MMP1, with an IC

conclusionThe integration of molecular modeling and bioactivity testing proved an effective method for the rapid discovery of targeted small molecule inhibitors. Cichoric acid demonstrated potent MMP1 inhibitory activity and thus represented a promising candidate for further development.

Indexed as

Drug DiscoveryMatrix Metalloproteinase 1Matrix Metalloproteinase InhibitorsTaraxacumDose-Response Relationship, DrugHumansMolecular Docking SimulationMolecular Dynamics SimulationMolecular StructureStructure-Activity RelationshipMatrix Metalloproteinase 1Matrix Metalloproteinase Inhibitorsbinding free energy calculationcichoric aciddandelionMMP1 inhibitormolecular dynamics simulationstructure-based virtual screening

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.